What is it about?
Ellagic acid directly and selectively targets mitochondria in cancerous B-lymphocytes. • Ellagic acid selectively increases mitochondrial ROS in cancerous B-lymphocytes. • Ellagic acid selectively releases mitochondrial cyt C in cancerous B-lymphocytes. • Ellagic acid can act as an anti-cancer candidate in CLL by selectively inducing apoptosis through mitochondrial pathway.
Featured Image
Why is it important?
Ellagic acid directly and selectively targets mitochondria in cancerous B-lymphocytes. • Ellagic acid selectively increases mitochondrial ROS in cancerous B-lymphocytes. • Ellagic acid selectively releases mitochondrial cyt C in cancerous B-lymphocytes. • Ellagic acid can act as an anti-cancer candidate in CLL by selectively inducing apoptosis through mitochondrial pathway.
Perspectives
Importance for cancer therapy and prevention
Dr Ahmad Salimi
Adrbabil university of medical sciences
Read the Original
This page is a summary of: Ellagic acid, a polyphenolic compound, selectively induces ROS-mediated apoptosis in cancerous B-lymphocytes of CLL patients by directly targeting mitochondria, Redox Biology, December 2015, Elsevier,
DOI: 10.1016/j.redox.2015.08.021.
You can read the full text:
Contributors
The following have contributed to this page
